156 studies found for:    Non-Alcoholic Steatohepatitis
Show Display Options
RSS Create an RSS feed from your search for:
Non-Alcoholic Steatohepatitis
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Treatment of Nonalcoholic Steatohepatitis With Pioglitazone
Conditions: Fatty Liver;   Nonalcoholic Steatohepatitis
Intervention: Drug: Pioglitazone
2 Completed
Has Results
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
Conditions: Nonalcoholic Steatohepatitis;   Liver Diseases
Interventions: Drug: Pentoxifylline;   Drug: Placebo
3 Recruiting Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)
Conditions: Nonalcoholic Steatohepatitis;   Hypogonadism
Intervention: Drug: testosterone undecanoate
4 Completed Betaine in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: Cystadane;   Drug: Identical Placebo
5 Recruiting Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Other: Omega-3 capsules-Fish Oil
6 Completed Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)
Condition: Non Alcoholic Steatohepatitis
Interventions: Procedure: AHA diet plus exercise with BIB placement;   Procedure: AHA diet plus exercise with sham BIB placement
7 Completed Effects of Alanine in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Intervention: Drug: L-alanine
8 Completed
Has Results
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: pentoxifylline (PTX);   Drug: placebo
9 Terminated
Has Results
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis (NASH);   Hepatic Steatosis
Interventions: Drug: Omega-3-acid ethyl esters (Lovaza);   Drug: Placebo
10 Completed The Effect of Protandim on Non-alcoholic Steatohepatitis
Condition: Non-Alcoholic Steatohepatitis
Interventions: Dietary Supplement: Protandim;   Dietary Supplement: Placebo
11 Recruiting Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis
Condition: Non-alcoholic Steatohepatitis
Interventions: Drug: Atorvastatin;   Drug: L-Carnitine;   Drug: Placebo
12 Completed The Impact of Deferasirox on Non-Alcoholic-Steatohepatitis
Conditions: Non-alcoholic Steatohepatitis;   Increased Iron Storage / Disturbed Distribution
Intervention: Drug: Exjade
13 Completed Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Dietary Supplement: Viusid;   Other: Hypocaloric Diet with controlled exercise
14 Completed Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis
Conditions: Nonalcoholic Steatohepatitis;   Insulin Resistance
Interventions: Dietary Supplement: Diamel;   Other: Placebo and lifestyle counseling
15 Unknown  Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis;   Nonalcoholic Fatty Liver Disease
Interventions: Drug: avandia;   Drug: metformin;   Drug: losartan
16 Recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin
17 Active, not recruiting Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Drug: GFT505 80mg;   Drug: GFT505 120mg;   Drug: Placebo
18 Recruiting Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Drug: GR-MD-02;   Drug: Placebo
19 Enrolling by invitation Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis
Condition: •Non-alcoholic Steatohepatitis (NASH)
Interventions: Drug: Ezetimibe;   Behavioral: Lifestyle
20 Active, not recruiting Simtuzumab (GS-6624) in the Treatment of Liver Fibrosis in Subjects With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Biological: Simtuzumab 75 mg;   Biological: Simtuzumab 125 mg;   Biological: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years